Comparing ischemic cardiovascular effectiveness and safety between individual SGLT-2 inhibitors and DPP-4 inhibitors in patients with type 2 diabetes: a nationwide population-based cohort study

• Автори: Hayeon Kim (Автор), Jun-Ho Seo (Автор), Jin Hyun Nam (Автор), Yejee Lim (Автор), Kyung Hee Choi (Автор), Kyungim Kim (Автор)
• Формат: Книга
• Опубліковано: Frontiers Media S.A., 2024-10-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

ObjectivesThis study compared the ischemic cardiovascular events (iCVEs) effectiveness and safety of initiating empagliflozin or dapagliflozin with those of dipeptidyl peptidase-4 inhibitors (DPP-4is), as well as the comparative effects between empagliflozin and dapagliflozin.MethodsUsing data from...